# Post Market Clinical Follow-Up KeriFuse®

> **NCT06546332** · — · ACTIVE_NOT_RECRUITING · sponsor: **Keri Medical SA** · enrollment: 97 (estimated)

## Conditions studied

- Arthritis

## Interventions

- **DEVICE:** KeriFuse®

## Key facts

- **NCT ID:** NCT06546332
- **Lead sponsor:** Keri Medical SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-05
- **Primary completion:** 2025-12
- **Final completion:** 2027-03
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546332, "Post Market Clinical Follow-Up KeriFuse®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*